Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High frequency of BRAF V600E mutations in ameloblastoma.
Kurppa KJ, Catón J, Morgan PR, Ristimäki A, Ruhin B, Kellokoski J, Elenius K, Heikinheimo K. Kurppa KJ, et al. Among authors: elenius k. J Pathol. 2014 Apr;232(5):492-8. doi: 10.1002/path.4317. Epub 2014 Jan 31. J Pathol. 2014. PMID: 24374844 Free PMC article.
Role of ErbB4 in breast cancer.
Sundvall M, Iljin K, Kilpinen S, Sara H, Kallioniemi OP, Elenius K. Sundvall M, et al. Among authors: elenius k. J Mammary Gland Biol Neoplasia. 2008 Jun;13(2):259-68. doi: 10.1007/s10911-008-9079-3. Epub 2008 May 3. J Mammary Gland Biol Neoplasia. 2008. PMID: 18454307 Review.
ErbB4 and its isoforms: patentable drug targets?
Paatero I, Elenius K. Paatero I, et al. Among authors: elenius k. Recent Pat DNA Gene Seq. 2008;2(1):27-33. doi: 10.2174/187221508783406602. Recent Pat DNA Gene Seq. 2008. PMID: 19075942 Review.
Mutated ERBB4: a novel drug target in metastatic melanoma?
Kurppa K, Elenius K. Kurppa K, et al. Among authors: elenius k. Pigment Cell Melanoma Res. 2009 Dec;22(6):708-10. doi: 10.1111/j.1755-148X.2009.00635.x. Epub 2009 Sep 7. Pigment Cell Melanoma Res. 2009. PMID: 19735458 No abstract available.
Potential of ErbB4 antibodies for cancer therapy.
Hollmén M, Elenius K. Hollmén M, et al. Among authors: elenius k. Future Oncol. 2010 Jan;6(1):37-53. doi: 10.2217/fon.09.144. Future Oncol. 2010. PMID: 20021208 Review.
Cell death or survival promoted by alternative isoforms of ErbB4.
Sundvall M, Veikkolainen V, Kurppa K, Salah Z, Tvorogov D, van Zoelen EJ, Aqeilan R, Elenius K. Sundvall M, et al. Among authors: elenius k. Mol Biol Cell. 2010 Dec;21(23):4275-86. doi: 10.1091/mbc.E10-04-0332. Epub 2010 Oct 13. Mol Biol Cell. 2010. PMID: 20943952 Free PMC article.
Proteolytic processing of ErbB4 in breast cancer.
Hollmén M, Liu P, Kurppa K, Wildiers H, Reinvall I, Vandorpe T, Smeets A, Deraedt K, Vahlberg T, Joensuu H, Leahy DJ, Schöffski P, Elenius K. Hollmén M, et al. Among authors: elenius k. PLoS One. 2012;7(6):e39413. doi: 10.1371/journal.pone.0039413. Epub 2012 Jun 22. PLoS One. 2012. PMID: 22761786 Free PMC article.
134 results